cabiralizumab
Showing 1 - 6 of 6
Triple Negative Breast Cancer Trial in Saint Louis (drug, biological, procedure)
Recruiting
- Triple Negative Breast Cancer
- Paclitaxel
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 19, 2022
Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Nivolumab, HuMax-IL8, Cabiralizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Nivolumab
- +2 more
-
Baltimore, MarylandJohns Hopkins University
Jul 28, 2022
Peripheral T Cell Lymphoma Trial in Ann Arbor, Columbus, Madison (Nivolumab, cabiralizumab)
Active, not recruiting
- Peripheral T Cell Lymphoma
- Nivolumab
- cabiralizumab
-
Ann Arbor, Michigan
- +2 more
Aug 13, 2021
Cancer Trial in Chicago (Nivolumab, Cabiralizumab, Urelumab)
Active, not recruiting
- Cancer
- Nivolumab
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Mar 14, 2022
Advanced Pancreatic Cancer Trial in Worldwide (Cabiralizumab, Nab-paclitaxel, Onivyde)
Active, not recruiting
- Advanced Pancreatic Cancer
- Cabiralizumab
- +8 more
-
Phoenix, Arizona
- +40 more
Apr 6, 2022
Pancreatic Cancer Stage IV Trial in La Jolla (Gemcitabine, Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Cabiralizumab)
Suspended
- Pancreatic Cancer Stage IV
- Gemcitabine
- +2 more
-
La Jolla, CaliforniaUCSD Moores Cancer Center
May 5, 2020